HT
ARNA

HAP Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

HAP Trading’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,080
Closed -$524K – 1569
2019
Q3 		$507K Buy
+11,080
New +$623K 0.04% 310
2013
Q3 		– Sell
-2,612
Closed -$175K – 928
2013
Q2 		$201K Buy
+2,612
New +$213K 0.01% 662

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HAP Trading's ARNA Position: Q4 2019 in Review

HAP Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2019, closing a stake of 11,080 shares — an estimated $524K sold.

HAP Trading first reported a position in ARNA in Q2 2013 and held it in 2 quarters. The position peaked at $507K in Q3 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

  • HAP Trading reported no remaining Arena Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
  • HAP Trading sold 11,080 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $524K.
  • HAP Trading first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • HAP Trading's Arena Pharmaceuticals Inc position peaked at $507K in Q3 2019.
  • 226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.